Hep Winter 2016 - Special Issue

Hep Winter 2016 - Special Issue

In every issue of HEP, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:



Through the Uprights: Former NFL star Rolf Benirsche kicks hepatitis C

Former NFL star turned activist Rolf Benirschke kicks hepatitis C.

From The Editor

Alive and Kicking

Rolf Benirschke became a hepatitis C virus (HCV) treatment advocate after he tested HCV positive while applying for life insurance in 1998.


Beware Herbal and Dietary Supplements

Herbal and dietary supplements are now a major risk factor for chemical-induced liver damage across the United States.

Do Your Meds Cost Too Much?:

#FairDrugPricesNow campaign calls for more transparency among drug companies.

Participate in a Virtual Hepatitis C Study

New app allows people living with HCV to take part in a research study aimed at tracking antiviral medication effects.

“Liver in a Box” Machine for Transplants

First hospital in the United States performs a liver transplant using a new high-tech machine are calling the “liver in a box.”

Treatment News

Eight Weeks of Harvoni

German study shows high hepatitis C virus cure rates after eight weeks of Harvoni (ledipasvir/sofosbuvir) treatment.

Upcoming Short-Course Treatment

An experimental hepatitis C virus (HCV) treatment regimen given for just six or eight weeks has shown promise in a mid-stage trial.

Treat All, Save Money

Treating all those with hepatitis C virus (HCV) who are on Medicaid would save money and improve the health and longevity of the population.

Curing Hep C After a Transplant

Hepatitis C virus (HCV) cure rates among those who have received a liver transplant are very good.


Hot topics